Even as Sequent Scientific is mainly focused on animal health active pharmaceutical ingredients, it is also looking to expand its human health business.
In an interview to CNBC-TV18, Manish Gupta, CEO of the company, said the company is focusing on scaling up its capabilities across all segments over the last two years.
The company has nine manufacturing facilities in India, Turkey, Spain and Brazil.
Speaking about revenue growth and profitability, he said, "We expect to close the current year FY17 upwards of Rs 1,000 crore as revenues".
Register Now For More Profit:
0 comments :
Post a Comment